Share on StockTwits

Oncothyreon (NASDAQ:ONTY) posted its quarterly earnings results on Monday. The company reported ($0.09) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.13) by $0.04, AnalystRatings.NET reports.

Oncothyreon (NASDAQ:ONTY) traded up 3.07% during mid-day trading on Monday, hitting $3.02. 228,409 shares of the company’s stock traded hands. Oncothyreon has a 1-year low of $1.64 and a 1-year high of $4.08. The stock has a 50-day moving average of $2.96 and a 200-day moving average of $2.92. The company’s market cap is $213.7 million.

Oncothyreon Inc (NASDAQ:ONTY) is a clinical-stage biopharmaceutical company focused primarily on the development of therapeutic products for the treatment of cancer.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.